Results 41 to 50 of about 1,816,514 (190)

Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. [PDF]

, 2014
OBJECTIVE: To use patient-level data from the ADVANCE study to evaluate the cost-effectiveness of transcatheter aortic valve implantation (TAVI) compared to medical management (MM) in patients with severe aortic stenosis from the perspective of the UK ...
Busca, R, Axel Linke, Amie Padhiar, Peter Wenaweser, Neil Moat, Piazza, N, Stuart Mealing, Johan Bosmans, Mealing, S, Stephen Brecker, Mark Sculpher, Ulrich J Gerckens, Nicolo Piazza, Rachele Busca, Padhiar, A, Sabine Bleiziffer, Tamburino, C, Sculpher, M, Bosmans, J, Gerckens, UJ, Bleiziffer, S, Linke, A, James Eaton, Eaton, J, Wenaweser, P, Moat, N, Corrado Tamburino, Brecker, S, Brecker, Stephen, Mealing, Stuart, Padhiar, Arnie, et al., Bosmans, Johan   +32 more
core   +1 more source

Biomechanical performance of the Bicaval Transcatheter System for the treatment of severe tricuspid regurgitation

Frontiers in Bioengineering and Biotechnology, 2023
Introduction: Tricuspid regurgitation (TR) is a relatively common valvular disease, which can result from structural abnormalities of any anatomic part of the tricuspid valve.
Fabrizio Crascì, Fabrizio Crascì, Stefano Cannata, Giovanni Gentile, Caterina Gandolfo, Salvatore Pasta, Salvatore Pasta   +6 more
doaj   +1 more source

Transcatheter Tricuspid Valve Intervention in Patients With Previous Left Valve Surgery

Canadian Journal of Cardiology, 2021
Scarce data exist on patients with previous left valve surgery (PLVS) undergoing transcatheter tricuspid valve intervention (TTVI). This study sought to investigate the procedural and early outcomes in patients with PLVS undergoing TTVI.This was a subanalysis of the multicenter TriValve registry including 462 patients, 82 (18%) with PLVS.
Guillem, Muntané-Carol, Maurizio, Taramasso, Mizuki, Miura, Mara, Gavazzoni, Alberto, Pozzoli, Hannes, Alessandrini, Azeem, Latib, Adrian, Attinger-Toller, Luigi, Biasco, Daniel, Braun, Eric, Brochet, Kim A, Connelly, Horst, Sievert, Paolo, Denti, Edith, Lubos, Sebastian, Ludwig, Daniel, Kalbacher, Rodrigo, Estevez-Loureiro, Neil, Fam, Christian, Frerker, Edwin, Ho, Jean-Michel, Juliard, Ryan, Kaple, Susheel, Kodali, Felix, Kreidel, Claudia, Harr, Alexander, Lauten, Julia, Lurz, Karl-Patrik, Kresoja, Vanessa, Monivas, Michael, Mehr, Tamim, Nazif, Georg, Nickening, Giovanni, Pedrazzini, François, Philippon, Fabien, Praz, Rishi, Puri, Ulrich, Schäfer, Joachim, Schofer, Gilbert H L, Tang, Ahmed A, Khattab, Martin, Andreas, Marco, Russo, Holger, Thiele, Matthias, Unterhuber, Dominique, Himbert, Marina, Urena, Ralph Stephan, von Bardeleben, John G, Webb, Marcel, Weber, Mirjam, Winkel, Michel, Zuber, Jörg, Hausleiter, Philipp, Lurz, Francesco, Maisano, Martin B, Leon, Rebecca T, Hahn, Josep, Rodés-Cabau   +57 more
openaire   +2 more sources

“Guidelines Recommendations on the Treatment of Tricuspid Regurgitation. Where Are We and Where Do We Go With Transcatheter Valve Intervention”

Frontiers in Cardiovascular Medicine, 2018
Tricuspid regurgitation (TR) is an important clinical problem because it is frequent and carries a poor prognosis when it is left uncorrected. However, there is still a lack of awareness of tricuspid disease in the medical community.
Alec Vahanian, Eric Brochet, Jean-Michel Juliard   +2 more
doaj   +1 more source

Echocardiographic Imaging to Guide Tricuspid Interventions

Structural Heart
Transcatheter tricuspid valve interventions may offer patients less invasive treatment alternatives to surgery. This review evaluates the use of echocardiography to determine anatomic suitability and guide the 2 most common classes of device currently ...
Rebecca T. Hahn, MD
doaj   +1 more source

Resurgence of the Tricuspid Valve: A Comprehensive Review of Transcatheter Interventions

Indian Journal of Clinical Cardiology
Tricuspid valve, once considered a “forgotten valve,” is experiencing a remarkable resurgence in clinical practice. Previously viewed as a secondary consequence of left-sided heart disease, tricuspid regurgitation is now recognized as an independent ...
Krishna Santhosh Vemuri, Tejaswi Penta, Deepak Sherpally, Bhavanadhar Penta   +3 more
doaj   +1 more source

Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Residual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge‐to‐edge (T‐TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce.
Fabian Voß, Philipp Mourikis, Fabian Nienhaus, Jafer Haschemi, Alexander Hoss, Tobias Zeus, Hanna Kowalski, Maximilian Spieker, Christian Jung, Patrick Horn, Hug Aubin, Artur Lichtenberg, Richard Truse, Malte Kelm, Amin Polzin   +14 more
wiley   +1 more source

Transcatheter therapies for tricuspid valve regurgitation

, 2020
: Tricuspid regurgitation, either isolated or associated with left-valve disease, has a strong impact on outcome. Surgical treatment of tricuspid regurgitation has increased in recent years, but in-hospital mortality remains high probably due to the risk
Fiorina C., Metra M., Adamo M., Zaccone G., Di Pasquale M., Curello S.   +5 more
core   +1 more source

Successful Percutaneous Retrieval of an Embolized MitraClip From the Right Subclavian Artery

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Single leaflet device attachment (SLDA) after mitral transcatheter valve edge‐to‐edge repair (M‐TEER) has been reported in up to 5% of patients. However, complete embolization of the M‐TEER device is exceedingly rare. Device retrievals in all previously reported cases were completed by vascular surgery cut down at the end. In this case, we are
Seyed Hossein Aalaei‐Andabili, Diljon S. Chahal, Shahab Tour Savadkohi   +2 more
wiley   +1 more source

Combined Transcatheter Tricuspid and Pulmonary Valve Replacement. [PDF]

, 2020
For patients with combined tricuspid and pulmonary valve disease, operative intervention carries high mortality risk. Published reports of combined transcatheter tricuspid and pulmonary valve replacement have been limited to single cases.A retrospective ...
Small, Adam J, Aksoy, Olcay, Salem, Morris M, Yang, Eric H, Levi, Daniel S, Aboulhosn, Jamil A   +5 more
core   +1 more source